Institutional investors purchased a net $32.6 million shares of AZN during the quarter ended June 2016 and now own 11.49% of the total shares outstanding. This is a greater percentage than is typical for companies in the Pharmaceuticals: Major industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FISHER ASSET MANAGEMENT LLC Bought 1.6 Million shares of AstraZeneca
SIMPLEX TRADING LLC Bought 97.1 Thousand shares of AstraZeneca
SEARLE & CO., INC. Bought 37.3 Thousand shares of AstraZeneca